glp-1 discovery Timeline of and clinical development. (a) Key events in Dual GLP-1/GIP receptor agonists mechanism

GLP-1RAs approved for use in the treatment of T2DM include semaglutide, liraglutide, and dulaglutide

Vitamin D A growing body of research highlights the critical role of vitamin D in supporting multiple body systems, including blood sugar balance, musculoskeletal strength, neurological and immune function

Additional Information & Research Details COA & Canadian Third-Party Testing Independent, verifiable Canadian third-party testing All third-party testing conducted by Integrity Peptides is performed through independent Canadian analytical laboratories

Approaches Achiev

Inconsistent use will greatly reduce its effectiveness

Bleeker, J.C., et al., Ketonesters as a Possible Novel Therapeutic Option for Patients With Fatty Acid Oxidation Disorders [abstract]